BXUS
PS
LM
JJS(
KKPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
argenxargenx.com HDPU  LD |
argenx is a global immunology company that engineers antibody-based medicines for severe autoimmune diseases by partnering with ac | Boston, Massachusetts | 1001-5000 | — |
Immunovantimmunovant.com  AT IGRM |
Immunovant, Inc. is a clinical-stage immunology company developing anti-FcRn targeted therapies to treat autoimmune diseases, with | New York, New York | 201-1000 | — |
UCBucb.com  DAAH LD |
UCB is a biopharmaceutical company developing and commercializing medicines in immunology and neurology, with five core products i | — | — | — |
Horizon Therapeuticshorizontherapeutics.com |
Horizon Therapeutics is a biotechnology research company based in Gaithersburg, Maryland, founded in 2018 and active in the biotec | Gaithersburg, Maryland | 1-10 | — |
Rocheroche.com  DK LR IA |
— | — | — | |
Novartisnovartis.com  XZKPXY |
Novartis is an innovative medicines company that discovers and commercializes medicines across cardiovascular, renal and metabolic | — | — | — |
Alexionalexion.com SU  BBAG |
Alexion, AstraZeneca Rare Disease is a rare disease company headquartered in Boston that pioneered complement-system medicines ove | Boston, Massachusetts | 5000+ | — |
PDX Pharmaceuticalspdxpharm.com |
PDX Pharmaceuticals (DBA Raksa Therapeutics) is a biopharmaceutical company developing next-generation combination immunotherapies | Portland, Oregon | 1-10 | — |
I-Mab Biopharmamabbiopharma.com |
I-Mab (NASDAQ: IMAB) is a U.S.-based global biotech company developing precision immuno-oncology agents for cancer, with its lead | Rockville, Maryland | 51-200 | — |
OSE Immunotherapeuticsimmuno.com |
OSE Immunotherapeutics is a biotechnology company developing first-in-class immuno-oncology (IO) and immuno-inflammation (I&I) ass | NANTES, Pays de la Loire | 51-200 | — |
ATB Therapeuticsatbtherapeutics.com |
ATB Therapeutics is a Belgian biotechnology company developing novel antibody therapies for cancer and auto-immune disease, center | Aye, Luxembourg | 51-200 | — |
Harbourbiomedharbourbiomed.com |
Harbour BioMed (HKEX: 02142) is a global biopharmaceutical company that discovers, develops, and commercializes novel antibody the | Cambridge, Massachusetts | 51-200 | — |
Apogee Therapeuticsapogeetherapeutics.com  LDLO EK |
Apogee Therapeutics is a biotechnology company founded in 2022 that develops novel antibody therapeutics for immunological and inf | Fully Remote, US | 201-1000 | — |
Alxnalxn.com |
Alxn (Alnylam Pharmaceuticals) is a biopharmaceutical company developing and delivering innovative medicines to treat patients wit | New Haven, Connecticut | 1001-5000 | — |
Immunocellularimmunocellular.com |
— | — | — | |
Aligos Therapeuticsaligos.com |
Aligos Therapeutics is a clinical-stage biotechnology company developing best-in-class small molecule therapies for liver and vira | South San Francisco, California | 51-200 | — |
Biotheryxbiotheryx.com |
Biotheryx is a clinical-stage biopharmaceutical company discovering and developing a portfolio of first-in-class protein degraders | San Diego, California | 11-50 | — |
Attoviaattovia.com |
Attovia is a clinical-stage biopharmaceutical company developing next-generation multispecific biologics for patients with high un | San Carlos, California | 51-200 | — |
Iterion Therapeuticsiteriontherapeutics.com |
Iterion Therapeutics is a clinical-stage biopharmaceutical company developing novel small-molecule therapies that target the Wnt/β | Houston, Texas | 11-50 | — |
Catalyst Biosciencescatbio.com |
Catalyst Bio is a research and clinical development biopharmaceutical company focused on rare disorders of the complement and coag | South San Francisco, California | 51-200 | — |
Alumisalumis.com |
Alumis is a biotechnology company developing lonigutamab, a late-stage anti-IGF-1R monoclonal antibody therapy with subcutaneous a | South San Francisco, California | 201-1000 | — |
Prelude Therapeuticspreludetx.com |
Prelude Therapeutics is a precision oncology company developing targeted protein degradation medicines, including KAT6A degraders | Wilmington, Delaware | 51-200 | — |
Morphos Teammorphos-team.net |
— | — | — | |
Dova Pharmceuticals, Incdova.com |
Health Care, Pharmaceutical | Durham, North Carolina | 51-200 | — |
Annexon Biosciencesannexonbio.com |
Annexon (Nasdaq: ANNX) is a clinical-stage biopharmaceutical company developing a portfolio of complement-inhibitor therapies targ | South San Francisco, California | 51-200 | — |
Catalystpharmacatalystpharma.com |
Catalyst Pharmaceuticals (Nasdaq: CPRX) is a biopharmaceutical company based in Coral Gables, Florida, that in-licenses, commercia | Coral Gables, Florida | 51-200 | — |
Modextxmodextx.com |
ModeX Therapeutics is a clinical-stage biopharmaceutical company developing multispecific biologics — multispecific antibodies and | Weston, Massachusetts | 51-200 | — |
Dewpoint Therapeuticsdewpointx.com |
Dewpoint is a biotechnology company developing drugs for conditions regulated by or arising from the dysfunction of biomolecular c | Boston, Massachusetts | 51-200 | — |
Shasqishasqi.com |
Shasqi is a biotech company developing the CAPAC® platform, a pre-targeting approach that uses click chemistry — a 2022 Nobel Priz | San Francisco, California | 11-50 | — |
Immunocoreimmunocore.com |
Immunocore Holdings plc (IMCR) is a biopharmaceutical company pioneering bispecific T cell receptor (TCR) therapies using its prop | — | — | — |
| Run live for more | ||||
argenx is a global immunology company that engineers antibody-based medicines for severe autoimmune diseases by partnering with academic researchers through its Immunology Innovation Program (IIP) to translate immunology breakthroughs into a portfolio of novel therapeutic antibodies.
Companies like argenx include Immunovant, UCB, Horizon Therapeutics, Roche, Novartis. See the full list of 24 competitors and alternatives above.
argenx has approximately 1001-5000 employees and is in the Biotechnology Research industry.
argenx is headquartered in Boston, Massachusetts.
argenx operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at argenx are listed above, including leaders across executive, finance, sales and operations.